Low-dose bevacizumab is effective in radiation-induced necrosis.
Case Rep Oncol
; 6(3): 598-601, 2013 Sep.
Article
em En
| MEDLINE
| ID: mdl-24474923
ABSTRACT
BACKGROUND:
Radiation-induced necrosis is a complication of brain irradiation. Treatment options are limited.METHODS:
The response to treatment with low-dose bevacizumab in 2 patients with radiation-induced necrosis was reported.RESULTS:
Both patients with metastatic melanoma, aged 48 and 51 years, had significant symptomatic and radiological improvement with low-dose bevacizumab treatment. Doses as low as 5 mg/kg every 6 weeks and 7.5 mg/kg i.v. every 4 weeks were used and were highly effective.CONCLUSIONS:
Low-dose bevacizumab is a solid option in the management of edema associated with radiation necrosis.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Revista:
Case Rep Oncol
Ano de publicação:
2013
Tipo de documento:
Article